Public Title Status Last Date Modified
Lupus Study Ongoing 30 Sep 2019
Narrowband ultraviolet B phototherapy versus visible light in HIV pruritus: a randomized controlled trial . . . Ongoing 15 Dec 2020
OLYMPUS - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients . . . Completed 20 May 2020
Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis Pending 13 Jul 2020
Open-label, randomised controlled trial of Efepoetin Alfa for treatment of Anemia associated with Chronic Kidney Disease Patients Not On Dialysis (ND-CKD). A non-inferiority trial compared to Methoxy . . . Ongoing 14 Aug 2020
Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients with Multidrug Resistant Tuberculosis . . . Completed 04 Mar 2020
Phase III Study of Evobrutinib in RMS Ongoing 27 Jan 2021
Post-Authorization Safety Study: Cohort Event monitoring for Dengvaxia, CYD-TDV Dengue Vaccine Ongoing 02 Jul 2020
Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines . . . Completed 02 Jul 2020
Randomized Sitagliptin Withdrawal Study (MK-0431-845) Completed 23 May 2019
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (MK-8835/PF-04971729) in Subjects with Type 2 Diabetes Melli . . . Completed 14 Aug 2020
RE-COVERY DVT/PE: global study on treatment and secondary prevention of acute venous thromboembolism Completed 02 Dec 2019
ROCKIES - A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients . . . Completed 20 May 2020
ROSuvastatin Evaluation as a Tuberculosis Treatment Adjunct Pending 29 Oct 2020
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes . . . Completed 14 Aug 2020
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) . . . Pending 26 Feb 2020
Sangobion®Iron+ Non-Interventional Study to Evaluate Changes in Hemoglobin Status in Subjects with Mild to Moderate Iron Deficiency Anemia (SANOIN Study) . . . Ongoing 13 Apr 2020
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Completed 30 Jun 2020
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially with Adacel® in Healthy Subjects . . . Ongoing 02 Jul 2020
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care   . . . Pending 27 Aug 2019
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy . . . Ongoing 25 Jun 2019
Study of cefiderocol or standard of care for paediatric patients with confirmed or suspected Gram-negative bacterial infections receiving a single dose and paediatric patients with confirmed or suspec . . . Pending 02 Mar 2020
Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) . . . Ongoing 24 May 2019
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) . . . Ongoing 17 Feb 2021
Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) . . . Completed 12 Mar 2020
©2021 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date